Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.
Jared Gollob, MD
Advertisement
Articles by Jared Gollob, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
New Phase 3 DISCREET Data Supports Long-Term Use of Apremilast for Genital Psoriasis
3
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
4
What Counts as “Short-Term” Systemic Corticosteroids in Atopic Dermatitis, and Why It Matters
5